Literature DB >> 17598823

The 2007 WHO Classification of Nervous System Tumors: newly recognized members of the mixed glioneuronal group.

Marc K Rosenblum1.   

Abstract

The clinical and pathologic features of two glioneuronal neoplasms newly incorporated in the 2007 revision of the WHO classification of nervous system tumors are reviewed. These are the papillary glioneuronal tumor and the rosette-forming glioneuronal tumor of the fourth ventricle.

Entities:  

Mesh：

Year:  2007        PMID： 17598823     DOI： 10.1111/j.1750-3639.2007.00079.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN： 1015-6305            Impact factor:   6.508


  24 in total

Review 1.  The new World Health Organization Classification of Central Nervous System Tumors: what can the neuroradiologist really say?

Authors:  A G Osborn; K L Salzman; M M Thurnher; J H Rees; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-11       Impact factor: 3.825

2.  Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.

Authors:  I-Chun Lai; Tai-Tong Wong; Cheng-Ying Shiau; Yu-Wen Hu; Donald Ming-Tak Ho; Kai-Ping Chang; Wan-Yuo Guo; Feng-Chi Chang; Muh-Lii Liang; Yi-Yen Lee; Hsin-Hung Chen; Sang-Hue Yen; Yi-Wei Chen
Journal:  Childs Nerv Syst       Date:  2015-03-08       Impact factor: 1.475

Review 3.  Rosette-forming glioneuronal tumor -- evidence of stem cell origin with biphenotypic differentiation.

Authors:  S Chakraborti; A Mahadevan; A Govindan; A Bhateja; S Dwarakanath; H R Aravinda; A A Phalguni; V Santosh; T C Yasha; P Rout; S Sampath; S K Shankar
Journal:  Virchows Arch       Date:  2012-09-13       Impact factor: 4.064

4.  Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT).

Authors:  Marco Gessi; Sally R Lambert; Libero Lauriola; Andreas Waha; V Peter Collins; Torsten Pietsch
Journal:  J Neurooncol       Date:  2012-07-20       Impact factor: 4.130

5.  Expression of TYMS in lymph node metastasis from low-grade glioma.

Authors:  Bingqian Ding; Ming Gao; Zhenjiang Li; Chenyang Xu; Shaokang Fan; Weiya He
Journal:  Oncol Lett       Date:  2015-06-24       Impact factor: 2.967

6.  Expression of β-transducin repeat-containing E3 ubiquitin protein ligase in human glioma and its correlation with prognosis.

Authors:  Jun Liang; Wei-Feng Wang; Shao Xie; Xian-Li Zhang; Wei-Feng Qi; Xiu-Ping Zhou; Jin-Xia Hu; Qiong Shi; Ru-Tong Yu
Journal:  Oncol Lett       Date:  2015-04-14       Impact factor: 2.967

7.  [WHO classification of tumours of the CNS: revised edition of 2007 with critical comments on the typing und grading of common-type diffuse gliomas].

Authors:  S Feiden; W Feiden
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

8.  Histologically proven, low-grade brainstem gliomas in children: 30-year experience with long-term follow-up at Mayo Clinic.

Authors:  Kamran A Ahmed; Nadia N Laack; Laurence J Eckel; Nicholas M Orme; Nicholas M Wetjen
Journal:  Am J Clin Oncol       Date:  2014-02       Impact factor: 2.339

9.  Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.

Authors:  David A Schomas; Nadia N Laack; Paul D Brown
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

10.  Papillary glioneuronal tumor-evidence of stem cell origin with biphenotypic differentiation.

Authors:  Aparna Govindan; A Mahadevan; D I Bhat; A Arivazhagan; Shrijeet Chakraborti; M S Suja; A A Phalguni; S Sampath; B A Chandramouli; S K Shankar
Journal:  J Neurooncol       Date:  2009-04-30       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.